Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology. Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focuses on sexual healthcare and pain relief management and we are evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. We have a number of relationships with key players.
Guildford, GB
Size (employees)
8 (est)
Futura Medical was founded in 1997 and is headquartered in Guildford, GB
Report incorrect company information

Key People/Management at Futura Medical

James Barder

James Barder

Bill Potter

Bill Potter


Futura Medical Office Locations

Futura Medical has an office in Guildford
Guildford, GB (HQ)
Surrey Research Centre 40 Occam Rd
Show all (1)
Report incorrect company information

Futura Medical Financials and Metrics

Futura Medical Financials

Futura Medical's revenue was reported to be £170.36 k in FY, 2016 which is a 478% increase from the previous period.

Revenue (FY, 2016)

170.4 k

Revenue growth (FY, 2015 - FY, 2016), %


Net income (FY, 2016)

(3.7 m)

EBITDA (FY, 2016)

(4.5 m)

EBIT (FY, 2016)

(4.6 m)

Market capitalization (18-Oct-2017)

29.3 m

Closing share price (18-Oct-2017)


Cash (31-Dec-2016)

12.4 m
Futura Medical's current market capitalization is £29.3 m.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


15 k150 k50 k125 k158.1 k75 k370.9 k43.9 k29.5 k170.4 k

Revenue growth, %


Operating expense total

2.6 m2.3 m1.6 m1.5 m2.3 m2.5 m2.9 m3.6 m6.1 m4.7 m


(2.6 m)(2.2 m)(1.5 m)(1.3 m)(2.1 m)(2.5 m)(2.5 m)(3.5 m)(6.1 m)(4.5 m)
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


2.6 m782.3 k1.8 m824.8 k2.6 m2.8 m990.6 k9.5 m4.2 m12.4 m

Accounts Receivable

82 k57.5 k20.8 k12 k20.4 k


23 k10.4 k10.8 k9.4 k8.4 k7.2 k35 k141.5 k163.8 k83.6 k

Current Assets

3.1 m1 m2.1 m1 m2.9 m3.2 m1.5 m10.3 m5.5 m13.4 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(2.3 m)(1.9 m)(1.4 m)(1.1 m)(1.8 m)(2.2 m)(2.2 m)(3 m)(5.1 m)(3.7 m)

Cash From Operating Activities

2.3 m(2 m)(1.3 m)(1 m)(2 m)(1.9 m)(2 m)(3.1 m)(5.4 m)(3.3 m)

Cash From Financing Activities

1 m2.3 m66.8 k3.6 m2.2 m181.3 k11.6 m24.8 k11.4 m

Net Change in Cash

103 k(1.9 m)1 m(964.4 k)1.8 m234.4 k(1.8 m)8.5 m(5.3 m)8.2 m
GBPY, 2016

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information